Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ABUS holding history

Arbutus Biopharma Corp in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABUS overviewAll 13F holders of ABUSFull Q2 2026 holdings

Shares (Q2 2026)
249,208
Value
$1.20M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of ABUS by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026249,208$1.20M<0.1%−115,263−31.6%ReducedHolders
Q1 2026364,471$1.64M<0.1%+217,179+147.4%AddedHolders
Q4 2025147,292$708.5K<0.1%−627,302−81.0%ReducedHolders
Q3 2025774,594$3.52M<0.1%+584,386+307.2%AddedHolders
Q2 2025190,208$587.7K<0.1%−2,084−1.1%ReducedHolders
Q1 2025192,292$671.1K<0.1%+91,287+90.4%AddedHolders
Q4 2024101,005$330.3K<0.1%−67,369−40.0%ReducedHolders
Q3 2024168,374$648.2K<0.1%+112,709+202.5%AddedHolders
Q2 202455,665$172.0K<0.1%−79,158−58.7%ReducedHolders
Q1 2024134,823$347.8K<0.1%−5,148−3.7%ReducedHolders
Q4 2023139,971$349.9K<0.1%+77,353+123.5%AddedHolders
Q3 202362,618$127.1K<0.1%−5,549−8.1%ReducedHolders
Q2 202368,167$156.8K<0.1%+31,502+85.9%AddedHolders
Q1 202336,665$111.1K<0.1%+13,376+57.4%AddedHolders
Q4 202223,289$54.3K<0.1%+23,289NewHolders
Q2 20220$00.0%−1,298−100.0%Sold outHolders
Q1 20221,298$4.00K<0.1%−32,810−96.2%ReducedHolders
Q4 202134,108$132.0K<0.1%+34,108NewHolders
Q3 20210$00.0%−62,310−100.0%Sold outHolders
Q2 202162,310$189.0K<0.1%−10,805−14.8%ReducedHolders
Q1 202173,115$244.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.